
Xaira, the biotech AI startup with the deepest funding round, launched its first model, X‑Cell, on Tuesday. The platform uses deep learning to generate virtual cell representations from multi‑omics data, enabling researchers to simulate cellular responses without physical experiments. Early benchmarks show X‑Cell can predict phenotypic outcomes with 92% accuracy across multiple disease models. The company plans to integrate the model into partner pharma pipelines by Q4 2026.

President Donald Trump has again blamed the Affordable Care Act for rising health‑care costs, citing premium spikes since the law’s rollout. Data show ACA individual premiums have risen 129% since 2014, outpacing the 68% increase in employer‑based plans, while deductibles...
Conservative lawmakers in Wyoming, Kansas and Oklahoma are advancing the Alliance Defending Freedom’s model CARE Act, which shields crisis pregnancy centers from state mandates to provide abortion referrals, information or contraception. The bill also grants centers the right to sue...

Switching health insurance plans in India can be done without losing benefits by using the portability option at renewal. The article outlines a step‑by‑step process that emphasizes timing, documentation, and full health disclosure to retain waiting‑period credits and existing‑condition coverage....
OXOS Medical announced FDA clearance for its MC2 portable X‑ray system designed specifically for paediatric imaging. The lightweight, wireless device enables bedside scans, allowing children to stay with caregivers while receiving low‑dose, high‑definition images. Hands‑free operation via a wireless foot...
START Center for Cancer Research has partnered with Trialing to broaden access to early‑phase oncology clinical trials throughout Europe. The exclusive agreement lets START distribute curated trial information and real‑time enrollment updates via Trialing’s platform, directly notifying oncologists when slots...

Kentucky counties are using opioid settlement money to purchase the NET device, a FDA‑cleared neuromodulation tool that eases withdrawal symptoms, at roughly $5,500 per patient. The company behind NET, NET Recovery, has secured about $1.2 million in contracts across more than...
A retrospective cohort of 201 Duchenne muscular dystrophy (DMD) patients and 202 matched controls revealed that a lower albumin‑globulin ratio (AGR) is strongly associated with poorer motor function and faster loss of ambulation. Logistic and Cox models showed lower AGR...
A nationwide study of 3,153 U.S. counties shows that the share of substance‑use‑disorder treatment facilities offering medication for alcohol use disorder (MAUD) rose from 34% in 2017 to 44% in 2021, then plateaued. Rural‑adjacent and rural‑remote counties lagged metropolitan areas...
A new knowledge‑infused neural framework extracts non‑taxonomic and ternary relations from patient‑generated texts, addressing gaps left by taxonomic‑only approaches. Using a four‑layer architecture, delayed fusion, rule‑based dictionaries, and BioBERT validation, the system processes 38,115 anxiety and depression documents. It achieves...
A qualitative study at Mulago National Referral Hospital found that structured nutrition education is virtually absent for HIV inpatients, with six of seven participants reporting no dietary counselling and no ward‑based nutritionist. Patients expressed positive attitudes toward nutrition and recognized...
A cross‑sectional study of 124 term infants examined how biological, maternal, and environmental factors predict neurodevelopment at six months using the ASQ‑3. Hierarchical regression showed that birth weight was the strongest and most consistent predictor across communication, gross motor, problem‑solving,...
Bangladesh faces a growing antimicrobial resistance crisis, with 26,200 AMR‑related deaths in 2019. A systematic review of 14 studies covering over 34,000 patients and clinicians found that antimicrobial stewardship (AMS) programs are fragmented, with only 31% of prescriptions guided by...

Clarity Pharmaceuticals presented Phase II Co‑PSMA data at the EAU Congress, showing its 64Cu‑SAR‑bisPSMA PET tracer outperforms the standard 68Ga‑PSMA‑11 in detecting prostate cancer recurrence at low PSA levels. In 50 men post‑radical prostatectomy, 64Cu‑SAR‑bisPSMA identified 63 lesions versus 24...

Cogent Biosciences announced that the U.S. FDA has accepted its new‑drug application for bezuclastinib in non‑advanced systemic mastocytosis (NonAdvSM), with a PDUFA target date of December 30 2026 and no advisory committee required. The filing is supported by the SUMMIT trial, which...

Siemens Healthineers has teamed up with the African Medical Centre of Excellence (AMCE) to bring advanced imaging, precision diagnostics and integrated cancer‑care solutions to Nigeria. The $300 million, Afreximbank‑backed hospital aims to become a regional hub for oncology, cardiology and haematology,...

Cognitive Stimulation Therapy (CST) is a low‑cost, evidence‑based psychosocial program for mild‑to‑moderate dementia that has been piloted at Bruyère Health Geriatric Day Hospital since January 2025. The pilot has completed three rounds and will conclude in July 2026, informing funding...

Ascendis Pharma released topline results from its Phase‑II New InsiGHTS trial evaluating TransCon hGH (lonapegsomatropin) administered once‑weekly versus daily somatropin in 49 prepubertal children with Turner syndrome. At week 52, the weekly formulation achieved an LS mean annualized height velocity...
A retrospective study of 78 Saudi hospital patients with Clostridioides difficile infection (CDI) found that continuous enteral feeding markedly lowered diarrhea severity compared with intermittent feeding (OR = 7.91, p < 0.001). Continuous feeding also stabilized serum sodium and reduced biochemical instability, while intermittent...

Chinese researchers at Shandong University have engineered the probiotic strain Escherichia coli Nissle 1917 to synthesize and deliver the anticancer drug Romidepsin directly within breast‑tumor tissue in mice. The bacteria colonized the tumors, releasing the drug locally and achieving tumor‑inhibiting...

Cancer survivorship is increasingly recognized, yet cognitive impairment—often called "brain fog"—remains invisible in most oncology workflows. Studies show up to 75% of patients experience cognitive changes during treatment, with roughly 35% continuing months or years afterward. The gap stems from...

President Trump’s TrumpRx website claims to offer the world’s lowest prescription‑drug prices, but a New York Times analysis finds the opposite. The site lists only a few dozen negotiated U.S. prices, omitting widely used drugs such as statins and many high‑cost cancer...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-175178521-56ff11d83df78c7d9e49337f.jpg)
Lexapro (escitalopram) is a widely used SSRI that commonly triggers mild side effects such as nausea, insomnia, and headaches during the first week of treatment. Most of these effects diminish after one to two weeks, but patients are advised not...

A study published in Gastroenterology demonstrates that stress during early life rewires gut‑brain pathways, increasing the risk of chronic digestive disorders. Mouse experiments showed sex‑specific motility changes and identified separate neural, hormonal, and serotonin mechanisms. Large human cohorts—over 40,000 Danish...
:max_bytes(150000):strip_icc():format(jpeg)/hydrocodone-withdrawal-4582579_FINAL-26af9601068c4a79860c1e523d48ed73.png)
Hydrocodone remains the most prescribed opioid in the U.S., with 83.6 million prescriptions in 2017 and 6.3 million misusers. Withdrawal typically starts 8–24 hours after the last dose, peaks on days two to three, and subsides within a week for most patients. Symptoms...
Fraser Health has deployed an artificial‑intelligence tool within its Meditech Expanse platform to automate discharge summary creation. The pilot, involving roughly 60 clinicians, cut average drafting time from 12.5 minutes to 5.5 minutes per patient. Users report the draft‑and‑review workflow...
OpenText unveiled its AI‑powered Fax Aviator at HIMSS, aiming to modernize healthcare fax workflows. The solution claims up to 85% labor savings by automating extraction, classification, and routing, and can process 2‑3 times more faxes without additional staff. Features such...

Health Secretary Wes Streeting’s NHS digital transformation faces warnings of nurse burnout. A Society of Occupational Medicine study of 339 nurses found digital technology stress significantly drives emotional exhaustion and burnout. While AI and digital tools can improve disease management...
An Italian neuroimaging study of 260 inpatients found that adverse childhood experiences (ACEs) are associated with poorer white‑matter integrity, especially in patients with bipolar disorder. In bipolar patients, higher exposure to physical abuse, emotional abuse, and neglect correlated with widespread...
Inspire Medical Systems reported a 12% rise in fourth‑quarter revenue to $269 million and a 14% increase for the full year, reaching $912 million, driven by both existing and new center growth. The company widened its 2026 revenue outlook to $950‑$1 billion, reflecting...
Zymeworks reported Q4 2025 revenue of $106 million, up from $76.3 million, while net loss narrowed to $81.1 million as operating expenses fell. The company highlighted Phase III zanidatumab data showing median PFS over one year and overall survival beyond two years in first‑line...
West Pharmaceutical reported Q4 2025 revenue of $850 million, up 7.5% reported and 3.3% organically, pushing full‑year net sales past $3 billion with 4% organic growth. Adjusted EPS rose 12% to $2.04 and free cash flow surged 70% to $469 million for the...

The Scottish Parliament rejected the Assisted Dying for Terminally Ill Adults Bill, voting 57 to 69 against it. The legislation would have made Scotland the first UK nation to legalise assisted dying, featuring strict safeguards such as dual‑doctor certification and...

PACS Group reported a $5.29 billion revenue in 2025, marking almost 30% year‑over‑year growth and expanding to 323 facilities in 17 states. CEO Jason Murray said the internal billing investigation is closed, while a federal probe continues without adding new risks....

The U.S. Federal Trade Commission announced it is closely monitoring how pharmaceutical companies respond to the upcoming patent cliff affecting numerous blockbuster drugs. FTC antitrust director Dan Guarnera said the agency’s “laser focus” on healthcare will target any anticompetitive conduct...

Unionization in U.S. nursing homes has altered staffing mixes without affecting overall care quality. Six years after a union vote, facilities added 0.34 LPN hours per resident day (4.2 % increase) while RN hours dropped 0.041 per resident day (9.1 % decline),...

Zymeworks will present Phase 1 data on its folate‑receptor‑alpha ADC ZW191 and preclinical results for a novel pan‑RAS inhibitor ADC platform at the AACR Annual Meeting. The oral presentation will detail dose‑escalation safety and efficacy in advanced solid tumours, while...

ORIC Pharmaceuticals announced that two preclinical abstracts on its PRC2‑targeting agent rinzimetostat (ORIC‑944) have been accepted for poster presentation at the 2026 AACR Annual Meeting. The data show rinzimetostat, an allosteric EED inhibitor, maintains potency against EZH1‑overexpressing complexes and key...
/file/attachments/orphans/RC22L9ACG95M_240482.jpg)
On 17 March the National Health Laboratory Service (NHLS) in South Africa lost access to its TrakCare information system after a power outage at its Johannesburg head office, revealing the absence of backup power. NHLS provides diagnostic pathology for over 80 %...

Sutter Health and Allina Health have signed a Letter of Intent to merge, creating a nonprofit system that spans Northern California, Minnesota and Wisconsin. The combined entity will include 39 hospitals, over 400 care sites, 18,000 physicians and 88,000 staff,...

Hospice providers face a turbulent 2026 outlook as regulatory scrutiny intensifies, staffing shortages deepen, and demand for end‑of‑life care surges. CMS has placed Georgia, Ohio, Arizona, California, Nevada and Texas under enhanced oversight to combat fraud, casting a shadow over...

A BMJ study of more than 600,000 Veterans Affairs patients with type‑2 diabetes found that glucagon‑like peptide‑1 (GLP‑1) drugs significantly lowered the risk of developing substance‑use disorders, including alcohol, cannabis, nicotine, cocaine and opioids. The analysis compared GLP‑1 therapy with...

A new analysis of the Multi‑Ethnic Study of Atherosclerosis (MESA) links each additional daily serving of ultra‑processed food to a 5.1% rise in incident cardiovascular disease (CVD). Participants in the highest consumption quintile faced a 66% higher CVD risk compared...

On March 17, 2026, House members introduced the bipartisan Physicians and the Healthcare Workforce Act, which would waive the $100,000 H‑1B filing fee imposed on foreign‑trained health‑care workers by a 2025 presidential proclamation. The legislation also bars any new H‑1B...

The American Hospital Association (AHA) placed an advertorial in The Wall Street Journal on March 17, emphasizing that hospitals are the heart of U.S. communities because they deliver care whenever and wherever needed. The piece outlines current challenges—rising costs, system complexity,...

Parents in England are scrambling to secure meningitis vaccinations for their children after a deadly outbreak in Kent that has claimed two lives and left 13 seriously ill. The surge in demand has exhausted vaccine inventories, leaving many pharmacies unable...

Inclined infant sleepers were banned in the United States in 2019 after the Consumer Product Safety Commission recalled millions of units following multiple infant deaths. A March 2026 study in Pediatrics found that 51 infants died in these products between...

Researchers at Worcester Polytechnic Institute created a machine‑learning model that scans MRI images and achieved 92.87% accuracy in distinguishing Alzheimer’s disease or mild cognitive impairment from healthy brains. The algorithm highlighted volume loss in the hippocampus, amygdala and entorhinal cortex...
An individual with mid‑range testosterone (488 ng/dL) plans a TRT protocol of 160 mg testosterone cypionate split twice weekly and 50 IU hCG weekly. They seek guidance on expected physiological changes, timeline, potential side effects such as hair loss, and whether the hCG...

A NIH‑backed multicenter trial of 140 pregnant adults found that weekly injectable extended‑release buprenorphine achieved significantly higher rates of illicit opioid abstinence than daily sublingual buprenorphine, while also reducing serious maternal adverse events. The study, published in JAMA Internal Medicine,...